LAUSR

The rise of industry-sponsored “Centers of Excellence” (COEs) in Pain Medicine reflects a troubling shift in how we define quality in healthcare. While framed as badges of clinical distinction, these designations often serve marketing goals more than meaningful improvements in patient care. Their frequently opaque, variable, and heavily volume-driven criteria raise fundamental concerns regarding how device manufacturers and for-profit industry partners define and promote these programs.